Tetagam P is a human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a defined high content of specific antibodies against the toxin produced by the bacteria Clostridium tetani.

Tetagam P contains tetanus immunoglobulin as active ingredient which is derived from human plasma and acts like endogenous constituent of plasma.

Tetagam P is used in: Post-exposure prophylaxis.

Immediate prophylaxis after tetanus prone injuries in patients: not adequately vaccinated, whose immunisation status is not known with certainty, with severe deficiency in antibody production.

Therapy of clinically manifest tetanus

Tetanus immunoglobulin should always be administered in conjunction with an active tetanus vaccination unless there are contraindications or confirmation of adequate vaccination.

1 ml contains: 

Active ingredients 
Human protein 100 - 170 mg thereof immunoglobulin at least 95% with antibodies to tetanus toxin at least 250 IU.

Other ingredients 
Aminoacetic acid (glycine), sodium chloride, HCl or NaOH (in small amounts for pH adjustment), water for injections.

Pack with 1 prefilled syringe with 1 ml.